Ocular Inflammation Clinical Trial
Official title:
Comparison of Topical Hydrocortisone Versus Dexamethasone Treatment for Inflammatory Secretions of the Conjonctiva in Patients With Ocular Prostheses
We propose to evaluate the efficacy of treatment with Hydrocortisone and Dexamethasone (in a cross-over design) in patients with ocular prostheses and significant functional discomfort.
There are more than 100,000 eye prosthesis wearers in France. Half of these patients are bothered by secretions or sandy sensations, or even chronic pain. Various anti-inflammatory treatments are proposed without scientific basis. A pilot study on a limited number of patients conducted in 2017 at the University Hospital of Rennes and published in 2019 showed the interest of Dexamethasone eye drops in these patients. However, this study was retrospective and not controlled. We therefore wish to propose a prospective, placebo-controlled, single-blind clinical study to define the value of anti-inflammatory treatment in patients with ocular prostheses. We propose to evaluate the efficacy of treatment with Hydrocortisone and Dexamethasone (in a cross-over design) in patients with ocular prostheses and significant functional discomfort. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05618730 -
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
|
Phase 1 | |
| Not yet recruiting |
NCT05248139 -
Safety and Effectiveness of Drop-free Small Incision Cataract Surgery
|
N/A | |
| Terminated |
NCT01214174 -
Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients
|
Phase 2 | |
| Completed |
NCT03332342 -
Closed Eye Neutrophils in Dry Eye Disease
|
N/A | |
| Completed |
NCT02128113 -
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
|
Phase 2 | |
| Completed |
NCT01808547 -
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
|
Phase 3 | |
| Active, not recruiting |
NCT04374656 -
Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
|
||
| Completed |
NCT00645671 -
Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery
|
Phase 3 | |
| Completed |
NCT00789971 -
Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification
|
N/A | |
| Completed |
NCT02786901 -
LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
|
Phase 3 | |
| Completed |
NCT00699153 -
Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery
|
Phase 3 | |
| Terminated |
NCT03596723 -
KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children
|
Phase 3 | |
| Completed |
NCT01576952 -
Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects
|
Phase 3 | |
| Withdrawn |
NCT03408015 -
Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease
|
Phase 4 | |
| Completed |
NCT03580473 -
Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification
|
Phase 2 | |
| Completed |
NCT04812951 -
Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery
|
Early Phase 1 | |
| Completed |
NCT03302273 -
Corneal Epithelial Stem Cells and Dry Eye Disease
|
N/A | |
| Completed |
NCT04690829 -
Biomarkers in Ocular Inflammation and Uveitis
|
||
| Withdrawn |
NCT01721694 -
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
|
Phase 3 | |
| Completed |
NCT03521791 -
Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.
|
Phase 4 |